Sunday, 29 March 2020

Japan News

  • Daiichi Sankyo expands drug discovery program

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities and research institutions based in Japan, 'Take a New challenge for Dr...Read more

  • BioDiem granted Japanese patent for BDM-1

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

    Singapore: Australian infectious disease therapy development company BioDiem has been granted a key Japanese patent for antimicrobial compound, BDM-I. The compund acts against a range of ...Read more

  • Zecotek and Hamamatsu Photonics join hands

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

    Singapore: Zecotek Photonics, a developer of leading-edge photonics technologies for medical, industrial and scientific markets, announced that its wholly owned subsidiary Zecotek Imaging S...Read more

  • Oramed granted patent in Japan for its POD Tech

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2013

    Singapore: Israel-based Oramed Pharmaceuticals, a developer of oral drug delivery systems, has announced receiving two additional patent approvals for its platform Protein Oral Delivery (PO...Read more

  • Novo Nordisk insulin analogue gets Japanese nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2013

    Singapore: Novo Nordisk announced that the Japanese Ministry of Health, Labour and Welfare has approved Ryzodeg (insulin degludec/insulin aspart) for the treatment of diabetes. In Japa...Read more

  • Mitsubishi Tanabe, Cytochroma end agreement

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Singapore: Japanese company Mitsubishi Tanabe Pharma and Canada-based Cytochroma have terminated a license agreement executed in 2008. The two companies have mutually agreed to the termina...Read more

  • Will Ranbaxy, Wockhardt incidents affect brand India?

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 29 May, 2013

    When the Indian generic sector forayed into the global arena almost two decades back, the affordability of its treatment options and its reliable quality drew eyeballs from potential market...Read more

  • Takeda Gemini II trial shows positive results

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase III trial. The trial evaluated v...Read more

  • Japanese stem cell firm ReproCell expands to US

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2013

    Singapore: ReproCELL, a Japanese stem cell technology company, has opened the company's first branch and US office in Boston. ReproCELL is the third Japanese life sciences company to have e...Read more

  • Japanese firm suspends trial of ArQule candidate

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2012

    Singapore: Japanese pharmaceutical company Kyowa Hakko Kirin temporarily suspended patient enrollment in an international phase III clinical study evaluating the combination of ARQ 197 (tiv...Read more

  • Japan BIOtech 2013 concludes in huge success

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    Singapore: "BIOtech 2013 in Japan", which recorded significant growth both in the scale and the quality, concluded in huge success. It witnessed 603 exhibitors from 25 countries (up from 49...Read more

  • Study shows Lipitor well-tolerated among Asians

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2012

    Singapore: A large-scale retrospective database analysis on atorvastatin (Lipitor) by Astellas Pharma and Pfizer Japan has demonstrated that atorvastatin is as well tolerated by the Asian p...Read more

  • Astellas to do interim analysis of cancer trial

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Apr, 2013

    Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a global phase III clinical trial evaluating Xtandi (enzalutamide) capsule...Read more

  • Indian pharma to put up a grand show at Tokyo fair

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2014

    Singapore: The Indian Department of Commerce is showcasing the achievement of the country's pharmaceutical sector at the 'Brand India Pharma' show in the Tokyo fair. The three-day show, In...Read more

  • Japan to revise medical device approval procedures

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 13 Feb, 2013

    Singapore: In order to speed up the approval process for medical devices, Japan is planning to introduce some changes in the accreditation procedures. News reports emerging from Japan state...Read more

  • Another Japanese university finds data manipulation for Novartis drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: The Jikei University School of Medicine has become the second Japanese university to find that clinical data had been manipulated for a Novartis Pharma drug that lowers blood pre...Read more

  • Prism to start PRI-724 trials to treat fibrosis

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2013

    Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, announced the close of an approximately $15 m...Read more

  • Takeshi Yura is AMRI Asia discovery VP

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

    Singapore: Dr Takeshi Yura has been promoted by AMRI to the position of vice president of discovery and development services, Asia. Dr Yura will report directly to Dr Thomas E. D'Ambra, cha...Read more



Survey Box

Are women in the industry getting the required recognition for their efforts?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls